AR
Advisory Research Portfolio holdings
AUM
$651M
1-Year Return
25.02%
This Quarter Return
+0.62%
1 Year Return
+25.02%
3 Year Return
+143.09%
5 Year Return
+422.22%
10 Year Return
+498.78%
AUM
$720M
AUM Growth
-$59.6M
(-7.6%)
Cap. Flow
-$29.1M
Cap. Flow
% of AUM
-4.04%
Top 10 Holdings %
Top 10 Hldgs %
17.21%
Holding
510
New
74
Increased
122
Reduced
203
Closed
86
Top Buys
| 1 |
GSK
GSK
|
$4.17M |
| 2 |
JBTM
JBT Marel Corporation
JBTM
|
$3.67M |
| 3 |
Northern Oil and Gas
NOG
|
$3.52M |
| 4 |
PRSU
Pursuit Attractions and Hospitality, Inc.
PRSU
|
$3.45M |
| 5 |
Fluor
FLR
|
$3.35M |
Top Sells
| 1 |
DEN
Denbury Inc.
DEN
|
$7.65M |
| 2 |
Reliance Steel & Aluminium
RS
|
$5.6M |
| 3 |
CHX
ChampionX
CHX
|
$4.75M |
| 4 |
Accenture
ACN
|
$4.01M |
| 5 |
On Holding
ONON
|
$3.48M |
Sector Composition
| 1 | Technology | 21.41% |
| 2 | Consumer Discretionary | 17.64% |
| 3 | Industrials | 15.62% |
| 4 | Healthcare | 11.67% |
| 5 | Financials | 10.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
451
Exelon
EXC
$43.9B
| – | – |
-6,291
| Closed | -$256K |
|
452
FedEx
FDX
$53.7B
| – | – |
-1,138
| Closed | -$282K |
|
453
Intel
INTC
$107B
| – | – |
-9,850
| Closed | -$329K |
|
454
Intapp
INTA
$3.67B
| – | – |
-46,778
| Closed | -$1.96M |
|
455
IPG Photonics
IPGP
$3.56B
| – | – |
-10,169
| Closed | -$1.38M |
|
456
Iron Mountain
IRM
$27.2B
| – | – |
-16,901
| Closed | -$960K |
|
457
Ironwood Pharmaceuticals
IRWD
$188M
| – | – |
-30,854
| Closed | -$328K |
|
458
Johnson Controls International
JCI
$69.5B
| – | – |
-3,998
| Closed | -$272K |
|
459
Lifestance Health
LFST
$2.09B
| – | – |
-124,188
| Closed | -$1.13M |
|
460
LoveSac
LOVE
$297M
| – | – |
-55,158
| Closed | -$1.49M |
|
461
Liquidia Corp
LQDA
$2.48B
| – | – |
-40,763
| Closed | -$320K |
|
462
Marvell Technology
MRVL
$54.6B
| – | – |
-5,529
| Closed | -$331K |
|
463
Newmont
NEM
$83.7B
| – | – |
-5,955
| Closed | -$254K |
|
464
Northrop Grumman
NOC
$83.2B
| – | – |
-568
| Closed | -$259K |
|
465
Nu Skin
NUS
$569M
| – | – |
-9,453
| Closed | -$314K |
|
466
Pacific Biosciences
PACB
$381M
| – | – |
-23,455
| Closed | -$312K |
|
467
Progressive
PGR
$143B
| – | – |
-2,672
| Closed | -$354K |
|
468
P3 Health Partners
PIII
$28.7M
| – | – |
-2,337
| Closed | -$349K |
|
469
Pinnacle West Capital
PNW
$10.6B
| – | – |
-8,407
| Closed | -$685K |
|
470
Prothena Corp
PRTA
$460M
| – | – |
-22,039
| Closed | -$1.5M |
|
471
Prudential Financial
PRU
$37.2B
| – | – |
-2,928
| Closed | -$258K |
|
472
Privia Health
PRVA
$2.86B
| – | – |
-17,214
| Closed | -$449K |
|
473
RELX
RELX
$85.9B
| – | – |
-17,127
| Closed | -$573K |
|
474
RTX Corp
RTX
$211B
| – | – |
-3,473
| Closed | -$340K |
|
475
Sana Biotechnology
SANA
$752M
| – | – |
-19,806
| Closed | -$118K |
|